1. Home
  2. GKOS vs VTMX Comparison

GKOS vs VTMX Comparison

Compare GKOS & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • VTMX
  • Stock Information
  • Founded
  • GKOS 1998
  • VTMX 1998
  • Country
  • GKOS United States
  • VTMX Mexico
  • Employees
  • GKOS N/A
  • VTMX N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • VTMX
  • Sector
  • GKOS Health Care
  • VTMX
  • Exchange
  • GKOS Nasdaq
  • VTMX Nasdaq
  • Market Cap
  • GKOS 5.1B
  • VTMX 2.0B
  • IPO Year
  • GKOS 2015
  • VTMX 2023
  • Fundamental
  • Price
  • GKOS $93.70
  • VTMX $27.59
  • Analyst Decision
  • GKOS Strong Buy
  • VTMX Sell
  • Analyst Count
  • GKOS 13
  • VTMX 2
  • Target Price
  • GKOS $155.00
  • VTMX $27.50
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • VTMX 231.9K
  • Earning Date
  • GKOS 04-30-2025
  • VTMX 04-23-2025
  • Dividend Yield
  • GKOS N/A
  • VTMX 2.58%
  • EPS Growth
  • GKOS N/A
  • VTMX N/A
  • EPS
  • GKOS N/A
  • VTMX 0.13
  • Revenue
  • GKOS $383,481,000.00
  • VTMX $258,927,122.00
  • Revenue This Year
  • GKOS $27.84
  • VTMX $18.81
  • Revenue Next Year
  • GKOS $27.99
  • VTMX $11.83
  • P/E Ratio
  • GKOS N/A
  • VTMX $19.56
  • Revenue Growth
  • GKOS 21.85
  • VTMX 15.06
  • 52 Week Low
  • GKOS $77.91
  • VTMX $21.30
  • 52 Week High
  • GKOS $163.71
  • VTMX $37.92
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 46.72
  • VTMX 71.40
  • Support Level
  • GKOS $87.17
  • VTMX $24.37
  • Resistance Level
  • GKOS $98.86
  • VTMX $24.50
  • Average True Range (ATR)
  • GKOS 5.12
  • VTMX 1.01
  • MACD
  • GKOS 1.70
  • VTMX 0.53
  • Stochastic Oscillator
  • GKOS 71.96
  • VTMX 96.92

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is a real estate company dedicated to the development and leasing of industrial buildings and distribution centers in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenues is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: